Suchergebnisse - "Yang, Tan"

PubPharm (10)

1

Core-shell cisplatin/SiO2 nanocapsules combined with PTC-209 overcome chemotherapy-Acquired and intrinsic resistance in hepatocellular carcinoma

enthalten in: Acta biomaterialia | 2023

von Li, W. | Solenne, T. | Wang, H. | +4

2

One-pot synthesis of a microporous organosilica-coated cisplatin nanoplatform for HIF-1-targeted combination cancer therapy

enthalten in: Theranostics | 2020

von Zhang, X. | He, C. | Liu, X. | +12

3

Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo

enthalten in: Drug delivery | 2019

von Li, W. | Yan, R. | Liu, Y. | +7

4

Biocompatible co-loading vehicles for delivering both nanoplatin cores and siRNA to treat hepatocellular carcinoma

enthalten in: International journal of pharmaceutics | 2019

von Li, M. | Zhao, P. | Fan, T. | +10

5

Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects

enthalten in: International journal of pharmaceutics | 2019

von Zhao, P. | Li, M. | Chen, Y. | +9

6

Enhancement of cisplatin efficacy by lipid-CaO2 nanocarrier-mediated comprehensive modulation of the tumor microenvironment

enthalten in: Biomaterials science | 2019

von He, C. | Zhang, X. | Yan, R. | +11

7

Enhancing the therapeutic effect via elimination of hepatocellular carcinoma stem cells using Bmi1 siRNA delivered by cationic cisplatin nanocapsules

enthalten in: Nanomedicine : nanotechnology, biology, and medicine | 2018

von Yang, T. | Chen, Y. | Zhao, P. | +12

8

Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375

enthalten in: Theranostics | 2016

von Yang, T. | Zhao, P. | Rong, Z. | +9

9

A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo

enthalten in: International journal of nanomedicine | 2014

von Huang, Y. | Yang, T. | Zhang, W. | +10

10

Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting

enthalten in: International journal of nanomedicine | 2014

von Ye, P. | Zhang, W. | Yang, T. | +5

1
[1]